Serotonergic Regulation of Cortisol Secretion in Dogs
- 1 August 1984
- journal article
- research article
- Published by The Endocrine Society in Endocrinology
- Vol. 115 (2) , 748-751
- https://doi.org/10.1210/endo-115-2-748
Abstract
The role of serotonin (5-HT) in the control of serum cortisol secretion was studied in 50 conscious beagle dogs. A significant rise in corticosteroids was observed after 1.5 and 3 mg/kg (P < 0.01) i.v. fenfluramine, an indirect serotonergic agonist, as well as after 2 (P < 0.05) and 3 mg/kg (P < 0.01) i.v. quipazine, a direct agonist of 5-HT receptors. Both drugs exhibited a dose-related effect. A lower dose of fenfluramine, 0.5 mg/kg, was ineffective when administered i.v. but raised serum corticol (P < 0.05) after direct injection into a lateral cerebral ventricle, through a chronically implanted brain cannula. The marked increases in corticosteroid concentration produced by the highest fenfluramine and quipazine doses were completely abolished by pretreatment with ketanserin, an antagonist of 5-HT2 receptors, which did not affect cortisol secretion when administered alone. The brain serotonergic system may play a role in the control of cortisol secretion in conscious dogs.This publication has 5 references indexed in Scilit:
- Serotonergic mechanism in the control of β-endorphin and acth release in male ratsLife Sciences, 1982
- Receptor binding profile of R 41 468, A novel antagonist at 5-HT2 receptorsLife Sciences, 1981
- Effect of Serotonin-Releasing Drugs on Serum Corticosterone Concentration in RatsNeuroendocrinology, 1980
- Canine Growth Hormone Responsiveness during Pentobarbital Anesthesia: A Method for Evaluating Serotoninergic Stimulatory ActionEndocrinology, 1979
- The Role of Biogenic Amines in the Regulation of Growth Hormone and Corticotropin Secretion in the Trained Conscious Dog*Endocrinology, 1978